They also investigated whether extending survival of Ebf1 haploinsufficient cells affected leukemogenesis by generating Ebf1+/–Bcl-xLTg (EB) mice, but did not report tumor development within ~250 days (36 weeks) of age. Here, EBF1 is linked to neoplasm.